Your prediction
Novozymes A/S B Stock
We can see a decrease in the price for Novozymes A/S B. Compared to yesterday it has lost -€0.620 (-1.170%).
Our community identified positive and negative aspects for Novozymes A/S B stock for the coming years. 1 users see the criterium "Return on equity" as a plus for the Novozymes A/S B stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Novozymes A/S B in the next few years
Pros
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novozymes A/S B vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novozymes A/S B | -1.170% | -1.483% | -4.079% | -5.141% | -3.029% | 6.685% | 16.791% |
| Solvay S.A. A | -0.590% | -0.735% | -1.747% | -14.258% | -12.109% | -71.374% | -72.079% |
| Eastman Chemical Co. | -3.240% | 4.996% | 7.022% | -40.903% | -36.303% | -33.068% | -32.743% |
| Air Products + Chemicals | -0.290% | -7.548% | -7.258% | -30.373% | -25.806% | -31.986% | -5.909% |
